Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;76(8):2636-2640.
doi: 10.1111/all.14810. Epub 2021 May 20.

Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy

Affiliations

Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy

Ricardo Madrigal-Burgaleta et al. Allergy. 2021 Aug.
No abstract available

Keywords: Drug allergy; anaphylaxis; de-labelling; drug desensitisation; personalised medicine.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Madrigal-Burgaleta R, Bernal-Rubio L, Berges-Gimeno MP, Carpio-Escalona LV, Gehlhaar P, Alvarez-Cuesta E. A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents. J Allergy Clin Immunol Pract. 2019;7(2):618-632.
    1. Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, et al. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: Value of diagnostic tools prior to desensitization. Allergy 2015;70(7):784-794.
    1. Hong DI, Madrigal-Burgaleta R, Banerji A, Castells M, Alvarez-Cuesta E. Controversies in Allergy: Chemotherapy reactions, desensitize or de-label? J Allergy Clin Immunol Pract. 2020;8(9):2907-2915.e1.
    1. Madrigal-Burgaleta R, Vazquez-Revuelta P, Marti-Garrido J, Lleonart R, Ali FR, Alvarez-Cuesta E. Importance of diagnostics prior to desensitization in new drug hypersensitivity: chemotherapeutics and biologicals. Curr Treat Options Allergy. 2020;7(1):1-13.
    1. Sloane D, Govindarajulu U, Harrow-Mortelliti J, et al. Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies. J Allergy Clin Immunol Pract. 2016;4(3):497-504.

LinkOut - more resources